Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

BAFF- and APRIL-dependent maintenance of antibody titers after immunization with T-dependent antigen and CD1d-binding ligand.

Shah HB, Joshi SK, Rampuria P, Devera TS, Lang GA, Stohl W, Lang ML.

J Immunol. 2013 Aug 1;191(3):1154-63. doi: 10.4049/jimmunol.1300263. Epub 2013 Jun 24.

2.

Coordination between T helper cells, iNKT cells, and their follicular helper subsets in the humoral immune response against Clostridium difficile toxin B.

Rampuria P, Lang GA, Devera TS, Gilmore C, Ballard JD, Lang ML.

J Leukoc Biol. 2017 Feb;101(2):567-576. doi: 10.1189/jlb.4A0616-271R. Epub 2016 Aug 26.

PMID:
27566831
3.

NKT-cell help to B lymphocytes can occur independently of cognate interaction.

Tonti E, Galli G, Malzone C, Abrignani S, Casorati G, Dellabona P.

Blood. 2009 Jan 8;113(2):370-6. doi: 10.1182/blood-2008-06-166249. Epub 2008 Oct 2.

4.

CD1d-dependent B-cell help by NK-like T cells leads to enhanced and sustained production of Bacillus anthracis lethal toxin-neutralizing antibodies.

Devera TS, Aye LM, Lang GA, Joshi SK, Ballard JD, Lang ML.

Infect Immun. 2010 Apr;78(4):1610-7. doi: 10.1128/IAI.00002-10. Epub 2010 Feb 1.

5.

Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL.

Benson MJ, Dillon SR, Castigli E, Geha RS, Xu S, Lam KP, Noelle RJ.

J Immunol. 2008 Mar 15;180(6):3655-9.

6.

DNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titers.

Gupta S, Clark ES, Termini JM, Boucher J, Kanagavelu S, LeBranche CC, Abraham S, Montefiori DC, Khan WN, Stone GW.

J Virol. 2015 Apr;89(8):4158-69. doi: 10.1128/JVI.02904-14. Epub 2015 Jan 28.

7.

Dispensability of APRIL to the development of systemic lupus erythematosus in NZM 2328 mice.

Jacob CO, Guo S, Jacob N, Pawar RD, Putterman C, Quinn WJ 3rd, Cancro MP, Migone TS, Stohl W.

Arthritis Rheum. 2012 May;64(5):1610-9. doi: 10.1002/art.33458.

8.

Reduction of CD1d expression in vivo minimally affects NKT-enhanced antibody production but boosts B-cell memory.

Lang GA, Johnson AM, Devera TS, Joshi SK, Lang ML.

Int Immunol. 2011 Apr;23(4):251-60. doi: 10.1093/intimm/dxq477. Epub 2011 Mar 12.

9.

Glycolipid-activated NKT cells support the induction of persistent plasma cell responses and antibody titers.

Devera TS, Shah HB, Lang GA, Lang ML.

Eur J Immunol. 2008 Apr;38(4):1001-11. doi: 10.1002/eji.200738000.

10.

Negative modulation of invariant natural killer T cell responses to glycolipid antigens by p38 MAP kinase.

Stuart JK, Bisch SP, Leon-Ponte M, Hayatsu J, Mazzuca DM, Maleki Vareki S, Haeryfar SM.

Int Immunopharmacol. 2010 Sep;10(9):1068-76. doi: 10.1016/j.intimp.2010.06.007. Epub 2010 Jun 11.

PMID:
20584631
11.

Follicular helper NKT cells induce limited B cell responses and germinal center formation in the absence of CD4(+) T cell help.

Tonti E, Fedeli M, Napolitano A, Iannacone M, von Andrian UH, Guidotti LG, Abrignani S, Casorati G, Dellabona P.

J Immunol. 2012 Apr 1;188(7):3217-22. doi: 10.4049/jimmunol.1103501. Epub 2012 Feb 29.

12.

In vitro and in vivo activation induces BAFF and APRIL expression in B cells.

Chu VT, Enghard P, Riemekasten G, Berek C.

J Immunol. 2007 Nov 1;179(9):5947-57.

13.

Deficient TACI expression on B lymphocytes of newborn mice leads to defective Ig secretion in response to BAFF or APRIL.

Kanswal S, Katsenelson N, Selvapandiyan A, Bram RJ, Akkoyunlu M.

J Immunol. 2008 Jul 15;181(2):976-90. Erratum in: J Immunol. 2008 Oct 1;181(7):5174.

14.

CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.

Hayworth JL, Mazzuca DM, Maleki Vareki S, Welch I, McCormick JK, Haeryfar SM.

Immunol Cell Biol. 2012 Aug;90(7):699-709. doi: 10.1038/icb.2011.90. Epub 2011 Nov 1.

PMID:
22041925
15.

NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.

Hermans IF, Silk JD, Gileadi U, Salio M, Mathew B, Ritter G, Schmidt R, Harris AL, Old L, Cerundolo V.

J Immunol. 2003 Nov 15;171(10):5140-7.

16.

Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide.

Croudace JE, Curbishley SM, Mura M, Willcox CR, Illarionov PA, Besra GS, Adams DH, Lammas DA.

BMC Immunol. 2008 Dec 3;9:71. doi: 10.1186/1471-2172-9-71.

18.

Synergistic induction of adaptive antitumor immunity by codelivery of antigen with α-galactosylceramide on exosomes.

Gehrmann U, Hiltbrunner S, Georgoudaki AM, Karlsson MC, Näslund TI, Gabrielsson S.

Cancer Res. 2013 Jul 1;73(13):3865-76. doi: 10.1158/0008-5472.CAN-12-3918. Epub 2013 May 8.

19.

Antitumor impact of interferon-γ producing CD1d-restricted NKT cells in murine malignant mesothelioma.

Tagawa T, Wu L, Anraku M, Yun Z, Rey-McIntyre K, de Perrot M.

J Immunother. 2013 Oct;36(8):391-9. doi: 10.1097/CJI.0b013e3182a801f2.

PMID:
23994885
20.

CD252 regulates mast cell mediated, CD1d-restricted NKT-cell activation in mice.

Gonzalez Roldan N, Orinska Z, Ewers H, Bulfone-Paus S.

Eur J Immunol. 2016 Feb;46(2):432-9. doi: 10.1002/eji.201545879. Epub 2015 Dec 9.

Supplemental Content

Support Center